Job/Unit: O42927
/KAP1
Date: 28-10-14 11:25:30
Pages: 7
Cross-Coupling of Dioxazaborocanes with α-Phosphate Enamides
procedure using enol phosphate 1b (50 mg, 0.11 mmol). Purifica-
tion was carried out by flash chromatography (PE/EtOAc: 95:5 to
8:2) to afford 3ba as a white solid (24 mg, 71%); All data are consis-
tent with literature.[3a]
EtOAc: 8:2); m.p. 158–159 °C. IR (neat): ν = 2971, 2932, 1712,
˜
1669, 1606, 1510, 1168 cm–1. 1H NMR (400 MHz, CDCl3): δ =
1.07 (s, 9 H), 2.88 (t, J = 4.6 Hz, 1 H), 3.83 (s, 6 H), 5.70 (t, J =
4.6 Hz, 1 H), 6.91 (d, J = 8.7 Hz, 4 H), 7.46 (d, J = 8.8 Hz, 4
H) ppm. 13C (100 MHz, CDCl3): δ = 24.9 (CH), 27.9 (3ϫ CH3),
55.5 (2ϫ CH3), 81.2 (C), 113.8 (4ϫ CH), 115.7 (2ϫ CH), 126.6
(4ϫ CH), 131.8 (2ϫ C), 142.4 (2ϫ C), 152.6 (C), 159.1 (2ϫ
C) ppm. MS (IS): m/z = 394.0 [M + H]+, 416.0 [M + Na]+. HRMS
(ESI) m/z [M – C4H9 + 2H]+ calcd. for C20H20NO4 338.13868,
found 338.13867.
tert-Butyl 2-(4-Methoxyphenyl)azacyclotridec-2-ene-1-carboxylate
(3ca): Title compound 3ca was prepared according to the typical
procedure using enol phosphate 1c (60 mg, 0.11 mmol). Purifica-
tion was carried out by flash chromatography (PE/EtOAc: 97:3 to
9:1) to afford 3ca as a white solid (32 mg, 75%); All data are consis-
tent with literature.[3a]
tert-Butyl 3,5-Bis(4-methoxyphenyl)-4H-1,4-oxazine-4-carboxylate
(3ha): Title compound 3ha was prepared according to the typical
procedure using enol phosphate 1h (90 mg, 0.13 mmol). Purifica-
tion was carried out by flash chromatography (PE/EtOAc: 95:5 to
8:2) to afford 3ha as a white solid (42 mg, 82%); Rf = 0.56 (PE/
tert-Butyl
3-(4-Methoxyphenyl)-4H-benzo[b][1,4]oxazine-4-carb-
oxylate (3da): Title compound 3da was prepared according to the
typical procedure using enol phosphate 1d (60 mg, 0.12 mmol). Pu-
rification was carried out by flash chromatography (PE/EtOAc:
95:5 to 85:15) to afford 3da as a white solid (38 mg, 93%); Rf =
EtOAc: 8:2); m.p. 128–129 °C. IR (neat): ν = 2979, 1707, 1606,
˜
0.69 (PE/EtOAc: 8:2); m.p. 128–129 °C. IR (neat): ν = 2976, 2921,
˜
1
1511, 1122 cm–1. H NMR (400 MHz, CDCl3): δ = 1.12 (s, 9 H),
1704, 1611, 1509, 1159 cm–1. 1H NMR (400 MHz, CDCl3): δ =
1.19 (s, 9 H), 3.81 (s, 3 H), 6.53 (s, 1 H), 6.86 (d, J = 6.8 Hz, 2 H),
6.91 (dd, J = 5.8, J = 3.6 Hz, 1 H), 7.10 (dd, J = 6.0, J = 3.6 Hz,
2 H), 7.27 (d, J = 8.8 Hz, 2 H), 7.67 (dd, J = 6.1, J = 3.4 Hz, 1
H) ppm. 13C (100 MHz, CDCl3): δ = 27.9 (3ϫ CH3), 55.5 (CH3),
82.0 (C), 114.0 (2ϫ CH), 116.0 (CH), 123.5 (CH), 124.8 (CH),
126.1 (2ϫ CH), 126.2 (CH), 126.9 (C), 128.1 (C), 129.4 (C), 134.8
(CH), 151.2 (C), 152.3 (C), 159.2 (C) ppm. MS (IS): m/z = 340.0
[M + H]+, 362.0 [M + Na]+. HRMS (ESI) m/z [M – C4H9 + 2H]+
calcd. for C16H14NO4 284.09173, found 284.09184.
3.82 (s, 6 H), 6.69 (s, 2 H), 6.90 (d, J = 8.8 Hz, 4 H), 7.46 (d, J =
8.8 Hz, 4 H) ppm. 13C (100 MHz, CDCl3): δ = 27.9 (3ϫ CH3), 55.5
(2ϫ CH3), 81.6 (C), 114.2 (4ϫ CH), 125.8 (4ϫ CH), 126.7 (2ϫ
C), 127.4 (2ϫ C), 137.0 (2ϫ CH), 152.9 (C), 159.1 (2ϫ C) ppm.
MS (IS): m/z = 396.0 [M + H]+, 418.0 [M + Na]+. HRMS (ESI)
m/z [M – C4H9 + 2H]+ calcd. for C18H18NO3 296.12812, found
296.12819.
Di-tert-butyl 2,5-Bis(4-methoxyphenyl)pyrazine-1,4-dicarboxylate
(3ia): Title compound 3ia was prepared according to the typical
procedure using enol phosphate 1i (80 mg, 0.10 mmol). Purification
was carried out by flash chromatography (PE/EtOAc: 95:5 to 85:15)
to afford 3ia as a white solid (32 mg, 68%); Rf = 0.79 (PE/EtOAc:
tert-Butyl
3-(4-Methoxyphenyl)-4H-pyrido[3,2-b][1,4]oxazine-4-
carboxylate (3ea): Title compound 3ea was prepared according to
the typical procedure using enol phosphate 1e (60 mg, 0.12 mmol).
Purification was carried out by flash chromatography (PE/EtOAc:
7:3 to 5:5) to afford 3ea as a white solid (34 mg, 83%); Rf = 0.47
8:2); m.p. 56–57 °C. IR (neat): ν = 2973, 1694, 1608, 1510,
˜
1
1121 cm–1. H NMR (400 MHz, CDCl3): δ = 1.22 (s, 18 H), 3.81
(s, 6 H), 6.45 (s, 2 H), 6.85 (d, J = 8.8 Hz, 4 H), 7.23 (d, J = 8.8 Hz,
4 H) ppm. 13C (100 MHz, CDCl3): δ = 28.0 (6ϫ CH3), 55.6 (2ϫ
CH3), 81.9 (2ϫ C), 113.8 (4ϫ CH), 116.2 (2ϫ C), 117.5 (2ϫ CH),
127.4 (4ϫ CH), 131.7 (2ϫ C), 150.7 (2ϫ C), 159.4 (2ϫ C) ppm.
MS (IS): m/z = 495.5 [M + H]+, 517.5 [M + Na]+. HRMS (ESI)
m/z [M + H]+ calcd. for C28H35N2O6 495.24896, found 495.24820.
(PE/EtOAc: 6:4); m.p. 151–152 °C. IR (neat): ν = 3093, 2973, 1720,
˜
1
1610, 1511, 1082 cm–1. H NMR (400 MHz, CDCl3): δ = 1.19 (s,
9 H), 3.81 (s, 3 H), 6.56 (s, 1 H), 6.85 (d, J = 8.8 Hz, 2 H), 7.08
(dd, J = 8.0, J = 4.8 Hz), 7.23 (dd, J = 8.0, J = 1.4 Hz, 1 H), 7.36
(d, J = 6.9 Hz, 2 H), 8.29 (dd, J = 4.8, J = 1.5 Hz, 1 H) ppm. 13C
(100 MHz, CDCl3): δ = 27.9 (3ϫ CH3), 55.5 (CH3), 82.5 (C), 114.0
(2ϫ CH), 122.1 (CH), 123.8 (CH), 126.3 (2ϫ CH), 127.3 (C), 127.7
(C), 133.9 (CH), 142.7 (C), 143.5 (CH), 147.2 (C), 151.5 (C), 159.4
(C) ppm. MS (IS): m/z = 341.0 [M + H]+, 363.0 [M + Na]+. HRMS
(ESI) m/z [M – C4H9 + 2H]+ calcd. for C15H13N2O4 285.08698,
found 285.08719.
7-(4-Methoxyphenyl)-2,3,4,5-tetrahydrooxepine (6aa): Title com-
pound 6aa was prepared according to the typical procedure using
lactone-derived enol phosphate 4a (60 mg, 0.17 mmol). Purification
was carried out by flash chromatography (PE/EtOAc/Et3N: 95:4:1)
to afford 6aa as a white solid (25 mg, 72%); Rf = 0.69 (PE/EtOAc:
95:5); m.p. Ͻ 50 °C. IR (neat): ν = 2935, 2857, 1667, 1600, 1510,
˜
tert-Butyl
3-(4-Methoxyphenyl)-4H-benzo[b][1,4]thiazine-4-carb-
1
1178 cm–1. H NMR (400 MHz, CDCl3): δ = 1.69 (qt, J = 6.1 Hz,
oxylate (3fa): Title compound 3fa was prepared according to the
typical procedure using enol phosphate 1f (60 mg, 0.12 mmol). Pu-
rification was carried out by flash chromatography (PE/EtOAc:
95:5 to 9:1) to afford 3fa as a white solid (37 mg, 87%); Rf = 0.65
1 H), 1.72 (qt, J = 5.8 Hz, 1 H), 2.31 (q, J = 6.0 Hz, 1 H), 3.82 (s,
3 H), 4.10 (t, J = 5.1 Hz, 1 H), 5.56 (t, J = 6.2 Hz, 1 H), 6.85 (d,
J = 8.8 Hz, 2 H), 7.48 (d, J = 8.8 Hz, 2 H) ppm. 13C (100 MHz,
CDCl3): δ = 25.7 (CH2), 26.5 (CH2), 32.2 (CH2), 55.5 (CH3), 72.9
(CH2), 106.9 (CH), 113.7 (2ϫ CH), 126.3 (2ϫ CH), 130.2 (C),
158.2 (C), 159.5 (C) ppm. MS (IS): m/z = 205.0 [M + H]+. HRMS
(PE/EtOAc: 9:1); m.p. 134–135 °C. IR (neat): ν = 2973, 1706,
˜
1134 cm–1. H NMR (400 MHz, CDCl3): δ = 1.21 (s, 9 H), 3.81 (s,
1
3 H), 6.36 (s, 1 H), 6.86 (d, J = 8.8 Hz, 2 H), 7.16 (t, J = 8.0 Hz,
1 H), 7.28 (m, 2 H), 7.36 (d, J = 8.7 Hz, 2 H), 7.67 (d, J = 8.0 Hz,
1 H) ppm. 13C (100 MHz, CDCl3): δ = 28.0 (3ϫ CH3), 55.5 (CH3),
81.9 (C), 112.3 (CH), 114.0 (2ϫ CH), 126.2 (CH), 126.5 (2ϫ CH),
126.8 (CH), 126.8 (CH), 126.9 (CH), 130.6 (C), 133.5 (C), 138.2
(C), 141.4 (C), 152.2 (C), 159.6 (C) ppm. MS (IS): m/z = 356.0 [M
+ H]+, 378.0 [M + Na]+. HRMS (ESI) m/z [M – C4H9 + 2H]+
calcd. for C15H14NOS 256.07906, found 256.07918.
(ESI) m/z [M
+
H]+ calcd. for C13H17O2 205.12231, found
205.12231.
Ethyl 2-(4-Methoxyphenyl)-1H-indole-1-carboxylate (6bc): Title
compound 6bc was prepared according to the typical procedure
using enol phosphate 5b (50 mg, 0.13 mmol). Purification was car-
ried out by flash chromatography (PE/EtOAc: 7:3 to 6:4) to afford
6bc as a colourless oil (34 mg, 89%); Rf = 0.50 (PE/EtOAc: 6:4).
1
tert-Butyl
2,6-Bis(4-methoxyphenyl)pyridine-1(4H)-carboxylate
IR (neat): ν = 3349, 2983, 1730, 1452, 1393, 1041 cm–1. H NMR
˜
(3ga): Title compound 3ga was prepared according to the typical
procedure using enol phosphate 1g (82 mg, 0.12 mmol). Purifica-
tion was carried out by flash chromatography (PE/EtOAc: 9:1 to
(400 MHz, CDCl3): δ = 1.15 (t, J = 7.1 Hz, 3 H), 2.00 (br., 1 H),
4.26 (q, J = 7.1 Hz, 2 H), 4.73 (s, 2 H), 6.58 (s, 1 H), 7.23–7.33 (m,
4 H), 7.41 (d, J = 7.6 Hz, 1 H), 8.16 (d, J = 8.3 Hz, 1 H) ppm. 13C
8:2) to afford 3ga as a white solid (32 mg, 68%); Rf = 0.51 (PE/ (100 MHz, CDCl3): δ = 14.0 (CH3), 63.2 (CH2), 65.2 (CH2), 110.9
Eur. J. Org. Chem. 0000, 0–0
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5